跳到内容
From alchemy to IPO : the business of biotechnology 预览资料
关闭预览资料
  • 预览此资料(Questia)

From alchemy to IPO : the business of biotechnology

著者: Cynthia Robbins-Roth
出版商: Cambridge, Mass. : Perseus, ©2000.
版本/格式:   图书 : 英语查看所有的版本和格式
提要:
It is impossible to dispute the extraordinary impact biotechnology is having on our everyday lives. Companies such as Genentech, Immunex, Amgen and Biogen hold the technological and intellectual keys to controlling our genetic destiny and moving science to a new apex of breakthrough cures. Written by a well-known industry insider, this title addresses the coming-of-age of biotech products and companies and traces  再读一些...
评估:

(尚未评估) 0 附有评论 - 争取成为第一个。

 

在图书馆查找

正在检索... 正在查找有这资料的图书馆...

详细书目

文件类型:
所有的著者/提供者: Cynthia Robbins-Roth
ISBN: 0738202533 9780738202532
OCLC号码: 44078478
注意: Includes index.
描述: xv, 253 p. : ill. ; 24 cm.
内容: Part 1 The Roots of Biotechnology --
Biotech in the Beginning --
Genentech: The Leader of the Pack --
The Amgen Story --
An Exception to Every Rule: Genzyme --
The Other Biotech: Monoclonal Antibodies --
Part 2 Biotechʼs Building Blocks --
Biotech Star Wars --
The Human Genome Project --
Tools for Genome Studies: BioChips and Microarrays --
Treating Disease at the Gene: Antisense Drugs --
Gene Therapy --
Following the Path of Communication: Signal Transduction --
Brand-New Knees: Tissue Engineering and Cell Replacement --
Building New Drugs: Combinatorial Chemistry --
Agricultural Biotechnology --
Part 3 The Business of Biotech: Product Development and Financing --
The Drug Development Process: From Test Tubes to Patients --
Speed Bumps and Brick Walls: Clinical Trial Design --
Biotech Bankers --
Initial Public Offerings --
Creative Financing --
Corporate Partners and the Urge to Merge --
Part 4 Biotech Stocks --
The Biotech Stock Landscape --
Picking the Right Stocks --
Appendix A Biotech Timeline --
Appendix B Biotechnology-Derived Products on the Market --
Appendix C Biotech Web Sites and Resources --
Appendix D BioVenture Consultantsʼ Biotech Stock Report.
责任: Cynthia Robbins-Roth.

摘要:

It is impossible to dispute the extraordinary impact biotechnology is having on our everyday lives. Companies such as Genentech, Immunex, Amgen and Biogen hold the technological and intellectual keys to controlling our genetic destiny and moving science to a new apex of breakthrough cures. Written by a well-known industry insider, this title addresses the coming-of-age of biotech products and companies and traces the history of biotechnology from its early inception in the ʼ70s to todayʼs heyday of new solutions and breakthrough treatments.

评论

用户提供的评论
正在检索weRead中的评论...
正在获取GoodReads评论...
正在检索Amazon中的评论...

标签

争取是第一个!
确认申请

您可能已经申请过这份资料。如果还是想申请,请选确认。

关闭窗口

请登入WorldCat 

没有张号吗?很容易就可以 建立免费的账号.